| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907474 | Experimental Hematology | 2008 | 6 Pages |
Abstract
We conclude that splenectomy constitutes a viable and safe therapeutic option for patients with T-LGL, splenomegaly, and refractory cytopenia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Vivek Subbiah, Aaron D. Viny, Steven Rosenblatt, Brad Pohlman, Alan Lichtin, Jaroslaw P. Maciejewski,